Studies on Adrenocortical Suppression Following Percutaneous Absorption of Topical Corticosteroids

  • ASO Miki
    Department of Dermatology, Tottori University School of Medicine
  • TAKEHAR Naohide
    Department of Dermatology, Tottori University School of Medicine
  • KANBE Naoto
    Department of Dermatology, Tottori University School of Medicine
  • INOUE Taeko
    Department of Dermatology, Tottori University School of Medicine
  • SHIMIZU Yasuyuki
    Department of Dermatology, Tottori University School of Medicine
  • MIHARA Motoyuki
    Department of Dermatology, Tottori University School of Medicine
  • SHIMAO Shuhei
    Department of Dermatology, Tottori University School of Medicine
  • USUI Toshiaki
    Division of Chemistry, Institute of Steroid Research Tottori University School of Medicine
  • KAWAMOTO Hiroko
    Division of Chemistry, Institute of Steroid Research Tottori University School of Medicine

Bibliographic Information

Other Title
  • 外用コルチコステロイド経皮吸収による副腎皮質機能抑制の検討
  • 外用コルチコステロイド経皮吸収による副腎皮質機能抑制の検討--0.05%Fluocinonide軟膏単純塗布の場合
  • ガイヨウ コルチコステロイド ケイヒ キュウシュウ ニヨル フクジン ヒシツ
  • —Observations on 0.05% Fluocinonide Ointment Applied under Simple Method—
  • ―0.05%Fluocinonide軟膏単純塗布の場合―

Search this article

Description

Five patients with psoriasis or eczema were treated for 7 consecutive days with 0.05% fluocinonide ointment 30∼60g daily (15∼30mg fluocinonide), and the serum 11-OHCS levels and the urinary 17-OHCS levels were estimated every day. Eosinophil counts and blood glucose levels were also estimated. The serum 11-OHCS levels were apparently lowered in one case with exfoliative dermatitis and slightly lowered in three cases with psoriasis vulgaris. The urinary 17-OHCS levels were not lowered in most cases. Decreasing of eosinophil counts were observed in two cases with eczematous dermatitis and exfoliative dermatitis. Increasing tendency of blood glucose were not observed. The clinical effect was almost equal with some other steroids. The results indicate that the use of 0.05% fluocinonide ointment 30-60g daily results in percutaneous absorption of fluocinonide to cause inhibition of adrenocortical function, though which is slightly, in patients with psoriasis or eczema.

Journal

Citations (7)*help

See more

References(2)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top